Nevro Corp. Accounts Payables 2011-2026 | NVRO

Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.

Main types of accounts payable

Type of liability	Example
To suppliers and contractors	Goods received but not yet paid for
Taxes and fees	VAT, income tax, etc., not paid on time
Salaries	Employee wages not paid
To budgets	Insurance contributions to funds not paid
To founders	Founders provided borrowed funds
To banks	Overdue loan payments
Other	Fines, penalties, forfeits, customer prepayments, etc.

Impact on the company's financial performance

Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios
Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence
Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals)
Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated

Annual Accounts Payables Nevro Corp.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
24.5 M	22.5 M	26.8 M	32 M	23.1 M	16 M	23.5 M	18.5 M	16.2 M	21.9 M	4.46 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
32 M	4.46 M	20.9 M

Quarterly Accounts Payables Nevro Corp.

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
20.3 M	22.9 M	21.2 M	22.5 M	28.9 M	30.3 M	29.2 M	26.8 M	31.8 M	-	27.1 M	32 M	32.8 M	31 M	29.1 M	23.1 M	23.1 M	23.1 M	23.1 M	16 M	16 M	16 M	16 M	23.5 M	23.5 M	23.5 M	23.5 M	18.5 M	18.5 M	18.5 M	18.5 M	16.2 M	16.2 M	16.2 M	16.2 M	21.9 M	21.9 M	21.9 M	21.9 M	4.46 M	4.46 M	4.46 M	4.46 M	3.18 M	3.18 M	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
32.8 M	3.18 M	20.2 M

Accounts Payables of other stocks in the Medical devices industry

Issuer	Accounts Payables	Price	% 24h	Market Cap	Country
Bruker Corporation BRKR	234 M	$ 36.74	-	$ 5.47 K	USA
ClearPoint Neuro CLPT	1.26 M	$ 9.38	-	$ 266 M	USA
Acutus Medical AFIB	2.76 M	-	-26.83 %	$ 2.62 M	USA
Cytosorbents Corporation CTSO	2.87 M	$ 0.59	-	$ 36.7 M	USA
AdaptHealth Corp. AHCO	352 M	$ 12.07	-	$ 1.63 B	USA
Allied Healthcare Products AHPI	1.21 M	-	3.58 %	$ 2.21 M	USA
Delcath Systems DCTH	2.66 M	$ 9.7	-	$ 347 M	USA
EDAP TMS S.A. EDAP	5.71 M	$ 3.45	1.77 %	$ 129 M	France
Edwards Lifesciences Corporation EW	228 M	$ 81.19	-	$ 47.5 B	USA
FONAR Corporation FONR	1.55 M	$ 18.6	-	$ 122 M	USA
Globus Medical GMED	98.9 M	$ 88.6	-	$ 12 B	USA
Apollo Endosurgery APEN	7.42 M	-	-	$ 475 M	USA
Helius Medical Technologies HSDT	531 K	$ 1.9	-	$ 1.15 M	USA
Integra LifeSciences Holdings Corporation IART	82.5 M	$ 9.31	-	$ 717 M	USA
Inspire Medical Systems INSP	36.6 M	$ 54.14	-	$ 1.59 B	USA
IRIDEX Corporation IRIX	5.38 M	$ 1.0	-	$ 16.9 M	USA
Integer Holdings Corporation ITGR	113 M	$ 85.63	-	$ 2.97 B	USA
OrthoPediatrics Corp. KIDS	18.8 M	$ 15.94	-	$ 374 M	USA
LENSAR LNSR	19 M	$ 5.89	-2.81 %	$ 70.4 M	USA
Avinger AVGR	777 K	-	-20.74 %	$ 369 K	USA
Medtronic PLC MDT	2.45 B	$ 86.28	-	$ 111 B	USA
Align Technology ALGN	109 M	$ 171.87	-	$ 12.9 B	USA
Myomo MYO	1.51 M	$ 0.7	-	$ 29.3 M	USA
AxoGen AXGN	2.89 M	$ 32.64	-	$ 1.5 B	USA
Axonics Modulation Technologies AXNX	9.07 M	-	-	$ 3.31 B	USA
Orthofix Medical OFIX	58.4 M	$ 11.77	-	$ 466 M	Curacao
Aziyo Biologics AZYO	4.79 M	-	1.37 %	$ 20.5 M	USA
Penumbra PEN	34.7 M	$ 329.87	-	$ 12.8 B	USA
Insulet Corporation PODD	75 M	$ 203.5	-	$ 14.3 B	USA
Sintx Technologies SINT	382 K	$ 2.53	0.4 %	$ 7.02 M	USA
Butterfly Network BFLY	4.25 M	$ 4.13	-0.24 %	$ 874 M	USA
Stryker Corporation SYK	1.8 B	$ 332.3	-	$ 127 B	USA
Tactile Systems Technology TCMD	4.97 M	$ 24.57	-	$ 562 M	USA
TELA Bio TELA	2.31 M	$ 0.63	5.47 %	$ 29.6 M	USA
TransMedics Group TMDX	10.4 M	$ 104.8	-	$ 3.56 B	USA
Tandem Diabetes Care TNDM	47.1 M	$ 19.17	-	$ 1.3 B	USA
BIOLASE BIOL	6.06 M	-	-13.19 %	$ 166 K	USA